Overview
Welcome to the Supply Chain Security Steering Committee
The Supply Chain Security Steering Committees goal is to identify common gaps in the supply chain. Supply chain security knowledge or practice that can be best addressed through collaboration by Consortium members and represent the biggest opportunity to improve patient safety and product integrity all while driving Rx-360’s mission to protect patient safety.
If you are interested in joining this Working Group please contact us at info@rx-360.org
Watch this Brief Member Testimonial
“I’ve been on the supply chain security steering committee for about five years now, and it’s a great way to sort of get a sense of the industry’s thinking in terms of supply chain security, and that’s upstream, downstream, logistics, distribution, illicit trade, counterfeits, and it’s been a tremendous source of knowledge and of ability to have discussions with your counterparts and other companies.”
Chris Trent, Director of Global Brand Protection for Johnson and Johnson
Rx-360 Responding to the Threat of Illicit Medicines: Methodologies for Monitoring, Investigation & Stakeholder Engagement
The distribution and sales of illicit products such as counterfeit, unapproved and diverted medicines are a global concern for pharmaceutical patients, health care professionals, regulators and manufacturers. Counterfeit drugs are not equivalent to the genuine […]
Rx-360 Understanding the Threat of Illicit Medicines: An Overview of Counterfeit, Tampered, Unapproved and Diverted Pharmaceuticals
The distribution and sales of illicit products such as counterfeit, unapproved and diverted medicines are a global concern for pharmaceutical patients, health care professionals, regulators and manufacturers. Counterfeit drugs are not equivalent to the genuine […]
Rx-360 Supply Chain Security White Paper: Incident Management Version 2.0
The threats of intentional adulteration, cargo theft, counterfeiting, illegal diversion, and tampering are a serious problem in our global marketplace; where criminals are profiting by putting unassuming patients at risk. These threats are product integrity […]